Graft-Versus-Host Disease

What Graft-Versus-Host Disease Means

Graft-versus-host disease, often called GVHD, is a condition that can happen after a patient receives stem cells or bone marrow from another person (a donor). In this situation, the donor’s immune cells see the patient’s healthy tissues as foreign and attack them. This immune reaction can cause inflammation and damage to many parts of the body, including the skin, liver, intestines, eyes, mouth, and other organs. GVHD can also rarely occur after a blood transfusion if the blood products are not specially treated to remove or inactivate immune cells.

Why GVHD Matters in Cancer Care

GVHD is an important concern for patients who receive allogeneic transplants, meaning stem cells or bone marrow from a donor rather than their own cells. These transplants are often used to treat blood cancers like leukemia and lymphoma, especially after high doses of chemotherapy or radiation that damage the patient’s own blood-forming cells. While the donor cells help rebuild the patient’s immune system and blood supply, they can also cause GVHD. This condition can range from mild to severe and may be life-threatening if not treated promptly.

Doctors work hard to match donors and patients closely to reduce the risk of GVHD. Sometimes, the donor’s immune cells also help attack any remaining cancer cells, a beneficial effect called graft-versus-tumor. However, managing GVHD remains a key part of transplant care.

What Patients Might Experience and See

GVHD can develop soon after transplant, usually within the first 10 to 100 days (acute GVHD), or much later, from about 3 months to 2 years after transplant (chronic GVHD). Early signs often include a rash, redness, or burning on the skin, especially on the palms and soles. Other symptoms may include nausea, vomiting, diarrhea, stomach cramps, jaundice (yellowing of the skin and eyes), dry or painful mouth, and eye irritation.

Chronic GVHD can cause ongoing inflammation and damage to skin, joints, muscles, and glands, sometimes leading to scarring or long-term problems. Because GVHD affects many organs, patients may notice a variety of symptoms and will need regular check-ups to monitor their health.

How GVHD Is Monitored and Managed

Doctors carefully watch for signs of GVHD after transplant through physical exams, blood tests, and sometimes biopsies of affected tissues. Early detection is important to start treatments that suppress the donor immune cells causing the problem. Treatments often include steroids and other medicines that reduce immune activity. Managing GVHD requires balancing treatment to control symptoms while avoiding too much immune suppression, which can increase infection risk.

Common Confusions and Related Terms

GVHD is sometimes confused with transplant rejection, but they are different. Transplant rejection happens when the patient’s immune system attacks the transplanted tissue, while GVHD is when donor immune cells attack the patient’s body. GVHD is also related to terms like allogeneic transplant (using donor cells) and autologous transplant (using the patient’s own cells). GVHD only occurs with donor cells, not autologous transplants.

GVHD can also be called TA-GVHD when it happens after a blood transfusion, which is rare and usually prevented by special blood treatments.

Questions Patients Can Ask Their Care Team

Patients and caregivers may find it helpful to ask about the risk of GVHD based on their donor match, what symptoms to watch for, how GVHD would be treated, and how it might affect recovery. It’s also useful to understand how GVHD differs from other transplant complications and what support is available during treatment.

Understanding GVHD in Context

Seeing the term GVHD in a medical report or discussion can be concerning, but it is one part of the transplant process. Not every patient develops GVHD, and treatments have improved over time. This entry provides general information and does not replace advice from your healthcare team. If GVHD is mentioned in your care, the best next step is to ask your doctor or nurse what it means for your specific situation and how they will monitor and manage it.